![]() |
市場調査レポート
商品コード
1800865
アテレクトミー装置の市場レポート:製品別、用途別、エンドユーザー別、地域別、2025~2033年Atherectomy Devices Market Report by Product Application, End User, and Region 2025-2033 |
||||||
カスタマイズ可能
|
アテレクトミー装置の市場レポート:製品別、用途別、エンドユーザー別、地域別、2025~2033年 |
出版日: 2025年08月01日
発行: IMARC
ページ情報: 英文 137 Pages
納期: 2~3営業日
|
世界のアテレクトミー装置の市場規模は、2024年に10億2,240万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに15億2,450万米ドルに達し、2025~2033年にかけて4.31%の成長率(CAGR)を示すと予測しています。末梢動脈疾患(PAD)の増加、大幅な技術発展、高齢者人口の増加、低侵襲手術の台頭、医療インフラ開発、新興経済諸国における償還政策などが、市場の成長を促す主な要因となっています。
末梢動脈疾患(PAD)患者の増加
人口の高齢化、糖尿病や肥満の増加により、世界的にPADの症例が増加しており、アテレクトミー装置市場の成長を牽引しています。米国では約800万~1,200万人がPADに罹患しており、特に50歳以上の患者が多く、40歳以上の650万人がPADと診断されています。アテレクトミー装置は、血管介入における重要な代替手段であるため、動脈プラークを除去するための低侵襲アプローチを提供します。この装置は血流を促進し、脚の痛みや疲労などの症状を軽減します。プラークを直接切断または蒸発させることで、動脈開存性を回復させ、重度のPAD患者の予後を大幅に改善します。
技術の進歩
アテレクトミー装置の技術革新には、方向制御機器や高周波回転技術の登場があり、これらの機器の有効性と安全性を向上させています。例えば、2020年の研究によると、軌道式アテレクトミー(プラークを研磨して除去する方法)は、閉塞した脚の動脈を90%の確率で効果的に開通させる一方、レーザーアテレクトミーは76%の確率で同様に血流を改善するとされています。このような患者予後の改善と外科医によるこれらの器具の嗜好が、アテレクトミー装置の成長を後押ししています。172人の患者を対象とした多施設共同研究において、ジェットストリームの使用は99%の成功率を示し、6ヵ月後および12ヵ月後の臨床的な標的病変の再灌流率はそれぞれ15%および26%でした。
新興市場への進出
市場の主要プレーヤーは、医療インフラ開発と医療支出の増大が注目される新興経済諸国に注目しており、それによって新たな機会がもたらされています。例えば、ブラジル、ロシア、インド、中国、南アフリカ(BRICS)の新興市場は、世界の医療分野における医療品とサービスの需要と供給の状況をますます形成しつつあります。2030年のGDPに占める医療支出の割合は、ブラジル8.4%、ロシア5.2%、インド3.5%、中国5.9%、南アフリカ10.4%と予測されています。より高度な治療の選択肢の実現によりこれらの市場への参入が可能になり、アテレクトミー装置の世界的な展開が拡大します。
The global atherectomy devices market size reached USD 1,022.4 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,524.5 Million by 2033, exhibiting a growth rate (CAGR) of 4.31% during 2025-2033. The rise in peripheral artery disease (PAD), significant technological advancements, rising ageing population, advent of minimally invasive surgeries, development of healthcare infrastructure, and reimbursement policies in emerging economies represent some of the key factors driving the growth of the atherectomy market.
Rising Cases of Peripheral Artery Disease (PAD)
The increasing cases of PAD at a global level due to ageing population and the rise in diabetes and obesity is leading the atherectomy device market growth. Approximately, PAD affects 8 to 12 million people in the United States, especially in those over 50. Out of these, 6.5 million over the age of 40 are diagnosed with PAD. Atherectomy devices provide a minimally invasive approach to remove arterial plaque as it is an important alternative in vascular interventions. The device enhances blood flow and reduces symptoms such as leg pain and fatigue. By directly cutting away or vaporizing the plaque, these devices help restore arterial patency, significantly improving patient outcomes in individuals with severe forms of PAD.
Technological Advancements
Major atherectomy devices innovations include the appearance of directionally controlled devices and high-frequency rotational technologies, which have continued to improve the effectiveness and safety of these devices. For instance, a 2020 study suggests that orbital atherectomy (which sands down plaque) effectively opens up blocked leg arteries 90 percent of the time, while laser atherectomy achieves similarly improved blood flow 76 percent of the time. These improvements in patient outcome and surgeon preference for these devices are propelling the growth of the atherectomy devices. In a multicenter study of 172 patients, Jetstream use had a 99% device success, and six-month and 12-month clinically-driven, target-lesion revascularization rates of 15% and 26%, respectively; with a one-year restenosis rate of 38% based on duplex imaging.
Expansion into Emerging Markets
Prominent key players are focusing on emerging economies where healthcare infrastructure development and growing healthcare spending is focused, thereby creating new opportunities for the key players in the market. For instance, the emerging markets of Brazil, Russia, India, China, and South Africa (BRICS) are increasingly shaping the landscape of the global health sector demand and supply for medical goods and services. Health spending as a percentage of GDP in 2030 is projected as - Brazil, 8.4%; Russia, 5.2%; India, 3.5%; China, 5.9%; South Africa, 10.4%. The penetration into these markets is enabled by realization of more advanced treatment alternatives, thus expanding the global footprint of atherectomy devices.
Directional Atherectomy Devices accounts for the majority of the market share
Directional atherectomy devices are created to precisely eliminate atherosclerotic plaque from obstructed arteries. These instruments provide the possibility of accurate control, which reduces vessel wall trauma, an important aspect for patient safety and recovery. Their ability to treat complex lesions in multiple vessel sizes makes them to be favoured by vascular specialists leading to the growth of the product segment. The capability of the devices to collect and remove plaque during the procedure sets these devices apart and is in a number of clinical situations preferable.
Peripheral Vascular accounts for the majority of the market share
The use of atherectomy devices in the treatment of peripheral vascular diseases is important because of the growing prevalence of PAD. Such devices play a key role in reestablishing the blood flow in leg arteries thus help to relieve the symptoms such as pain and mobility problems. The demand in this segment is determined by minimally invasive character of the procedure which allows short recovery period and lower risks of complications in comparison to conventional surgery making patient outcomes and treatment efficiencies higher.
Hospitals accounts for the majority of the market share
Hospitals are the main users of atherectomy devices because these procedures are very complex and need advanced infrastructure and highly trained healthcare professionals. The growth of the segment is followed by the growth of the number of vascular surgeries conducted in hospitals, fueled by investments into advanced technologies and in the training programs of health providers. Ability of hospitals to offer all types of care including post-operative requirements also helps in making them the dominant subject in the market.
North America dominates the market
The report has also provided a comprehensive analysis of all the major markets which include North America (United States, Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others); Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others); Latin America (Brazil, Mexico, Others), and Middle East and Africa. According to the report, North America was the largest market for atherectomy devices.
North America is the largest market for atherectomy because of high prevalence of cardiovascular diseases, developed healthcare system and the key market players in the region. The United States is the biggest market in this region because of the favourable reimbursement scenarios, clinical trials, and solid governmental support for research and development in advanced medical devices. The commitment of the region to application of new healthcare solutions is driving the market growth.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)